2020
19. DOĞU, O. Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease: the Turkish experince. TURKİSH JOURNAL OF MEDİCAL SCİENCES, 2020, , 66-85. 1000 + 0

10.3906/sag-1904-150

2019
18. DOĞU, O. Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study. JOURNAL OF NEUROLOGY, 2019, 266, 3047-3047. 1000 + 0

17. DOĞU, O. Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease:the Turkish experience. TURKİSH JOURNAL OF MEDİCAL SCİENCES, 2019, 50, 1-6. 1000 + 0

10.3906/sag-1904-150

2018
16. DOĞU, O. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin. JOURNAL OF NEUROLOGY, 2018, 265, 402-409. 1000 + 0

10.1007/s00415-017-8698-2

2017
15. DOĞU, O. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. PARKİNSONİSM RELATED DİSORDERS, 2017, 39, 64-70. 1000 + 0

10.1016/j.parkreldis.2017.03.012

14. DOĞU, O. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. MOVEMENT DİSORDERS CLİNİCAL PRACTİCE, 2017, 5, -. 1000 + 0

10.1002/mdc3.12556

13. DOĞU, O. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. PARKİNSONİSM RELATED DİSORDERS, 2017, 39, 64-70. 1000 + 0

10.1016/j.parkreldis.2017.03.012

12. DOĞU, O. title Epigenetic approach to early-onset Parkinson’s disease: low methylation status of iSNCA/i and iPARK2/i promoter regions/title. NEUROLOGİCAL RESEARCH, 2017, 39, 965-972. 1000 + 0

10.1080/01616412.2017.1368141

2016
11. DOĞU, O.; ERER ÖZBEK, Ç.; ZARİFOĞLU, M.; ÇEÇENER, G.; TUNCA, B.; AKSOY, S.; ELİBOL, B.; KALEAĞASI, Ş.; SAKA TOPÇUOĞLU, E. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson’s patients and genotype-phenotype correlations. CLİNİCAL NEUROLOGY AND NEUROSURGERY, 2016, 148, 147-153. 700 + 0

2014
10. Unal Gulsuner, H.; Gulsuner, S.; Mercan, F.; Onat, O.; Walsh, T.; Shahin, H.; Lee, M.; Dogu, O.; Kansu, T.; Topaloglu, H. Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease. PROCEEDİNGS OF THE NATİONAL ACADEMY OF SCİENCES, 2014, 111, 18285-18290. 100 + 140

http://dx.doi.org/10.1073/pnas.1419581111


Alıntılanma Sayısı: 28

2013
9. Dogu, O.; Krebs, C.; Kaleagasi, H.; Demirtas, Z.; Oksuz, N.; Walker, R.; Paisán-Ruiz, C. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. WİLEY-BLACKWELL, 2013, 84, 350-355. 800 + 0

http://dx.doi.org/10.1111/cge.12079

2012
8. Lohmann, E.; Dursun, B.; Lesage, S.; Hanagasi, H.; Sevinc, G.; Honore, A.; Bilgic, B.; Gürvit, H.; Dogu, O.; Kaleagası, H. Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. WİLEY-BLACKWELL, 2012, 19, 769-775. 100 + 0

http://dx.doi.org/10.1111/j.1468-1331.2011.03639.x

7. Rana, A.; Kabir, A.; Dogu, O.; Patel, A.; Khondker, S. Prevalence of Blepharospasm and Apraxia of Eyelid Opening in Patients with Parkinsonism, Cervical Dystonia and Essential Tremor. S. KARGER AG, 2012, 68, 318-321. 700 + 0

http://dx.doi.org/10.1159/000341621

2008
6. Paisan-Ruiz, C.; Dogu, O.; Yilmaz, A.; Houlden, H.; Singleton, A. SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. OVİD TECHNOLOGİES (WOLTERS KLUWER HEALTH), 2008, 70, 1384-1389. 800 + 0

http://dx.doi.org/10.1212/01.wnl.0000294327.66106.3d

2007
5. Louis, E.; Dogu, O. Does Age of Onset in Essential Tremor Have a Bimodal Distribution? Data from a Tertiary Referral Setting and a Population-Based Study. S. KARGER AG, 2007, 29, 208-212. 1000 + 0

http://dx.doi.org/10.1159/000111584

2004
4. Sevim, S.; Dogu, O.; Kaleagasi, H.; Aral, M.; Metin, O.; Camdeviren, H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75, 226-230. 750 + 430

Alıntılanma Sayısı: 86

3. Dogu, O.; Apaydin, D.; Sevim, S.; Talas, D.; Aral, M. Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease. ELSEVİER BV, 2004, 106, 93-96. 900 + 0

http://dx.doi.org/10.1016/j.clineuro.2003.10.012

2003
2. Dogu, O.; Sevim, S.; Camdeviren, H.; Sasmaz, T.; Bugdayci, R.; Aral, M.; Kaleagasi, H.; Un, S.; Louis, E. Prevalence of essential tremor - Door-to-door neurologic exams in Mersin Province, Turkey. NEUROLOGY, 2003, 61, 1804-1806. 700 + 615

Alıntılanma Sayısı: 123

1. Sevim, S.; Dogu, O.; Camdeviren, H.; Bugdayci, R.; Sasmaz, T.; Kaleagasi, H.; Aral, M.; Helvaci, I. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. NEUROLOGY, 2003, 61, 1562-1569. 650 + 555

Alıntılanma Sayısı: 111

2019
2. FİDANCI, H.; ÖKSÜZ, N.; özal, ş.; ADIGÜZEL, U.; KALEAĞASI, Ş.; DOĞU, O. Retinal nerve fiber layer thickness in patients with essential tremor and Parkinson’s disease. JOURNAL OF SURGERY AND MEDİCİNE, 2019, 3, 44-51. 40 + 0

10.28982/josam.661757

2017
1. KOÇ, Z.; ÖZCAN KARA, P.; DOĞU, O. F-18 FDG PET/CT image of alzheimer like primaryprogressive aphasia. GLOBAL IMAGİNG INSİGHTS, 2017, 2, 1-2. 0 + 0

10.15761/GII.1000125

1. ÖKSÜZ, N.; DOĞU, O. Nörolojik ve Psikiyatrik Hastalıklarda Derin Beyin Stimülasyonu (DBS), ISBN: 978-605-9358-66-8, US Akademi, Baskı Sayısı: 1, Baskı Adet Sayısı: , 300 Sayfa, Türkçe, , Türkiye, 2019. 0

2. Leentenjens, A.; KOCABIÇAK, E.; TUĞCU, B.; DOĞU, O.; ELİBOL, B.; TÜFEKÇİOĞLU, Z. Nörolojik ve Psikiyatrik Hastalıklarda Derin Beyin Stimülasyonu (DBS) El Kitabı, ISBN: 9786059358668, US Akademi, Baskı Sayısı: 1, Baskı Adet Sayısı: , 300 Sayfa, Türkçe, İzmir, Türkiye, 2019. 0

1. HAMZAOĞLU, V.; ÖZALP, H.; DOĞU, O.; DAĞTEKİN, A.; AVCI, E.; AYDIN, S.; BAĞDATOĞLU, C., Deep Brain Stimulation for Movement Disorders: A Single Center Study İnvolving 135 Nuclei Electrode İmplantaion wİthout any İntra-Cerebral Hemorrhage. 4. Clinical Neuroscience Course, 2019-10-17, 2019-10-19, Samsun, , . 60

1. DOĞU, O., C19orf12 p. Thr11Met mutation is frequent among adult Turkish patients with MPAN.. movement disoredrs society meeting, 2017-06-04, 2017-06-08, , , . 50

1. BOZDAĞ, M.; ÖKSÜZ, N.; DOĞU, O., Parkinson Hastalığında Re-emergent Tremor. Hareket Bozukluklarında Tedavi Sempozyumu, 2018-05-10, 2018-05-12, , Türkiye, . 50

1. HAMZAOĞLU, V.; ÖZALP, H.; DOĞU, O.; KOYUNCU, Ö.; UYGUR, S.; BAĞDATOĞLU, C., Travmaya Sekonder Holmes Tremorunun Tedavisinde Unilateral Talamik Vim ve Pallidum Stimülasyonu: Bir Olgu Sunumu. Türk Nöroşirürji Derneği 33. Bilimsel Kongresi, 2019-04-11, 2019-04-14, , Türkiye, . 16

2. INTEREST IN CD2 study. An international observational prospective Study on long-term response to Botulinum toxin type A (BoNT-A) injections in subjects suffering from idiopathic cervical dystonia (CD) – pharmaco-economic impact, H2020, Proje No: , EUR, Araştırmacı, 2018,Tamamlandı. 0

1. Merck Preladenant Phase 3 Early Parkinson’s Disease P05664 study, Dünya Bankası, Proje No: , EUR, Araştırmacı, 2013,Tamamlandı. 0

1. NEUROLOGY , [ 2016 : 5 ] [ 2015 : 5 ] [ 2014 : 10 ] . 100

1. Bruce S. Schoenberg Award in Neuroepidemiology American Academy of Neurology, 2017-04-21, San Francisco, Amerika Birleşik Devletleri. 100

1. Movement Disorders Society , Üye No: 356, Amerika Birleşik Devletleri, 2015-06-12-Devam ediyor.